» Articles » PMID: 24716541

Insights into the Infiltrative Behavior of Adamantinomatous Craniopharyngioma in a New Xenotransplant Mouse Model

Overview
Journal Brain Pathol
Date 2014 Apr 11
PMID 24716541
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Adamantinomatous craniopharyngiomas (adaCP) cause hypothalamic pituitary dysfunction. Elucidation of pathomechanisms underlying tumor progression is essential for the development of targeted chemotherapeutic treatment options. In order to study the mechanisms of tumor outgrowth, we implanted human primary adaCP tissue from three different surgical specimens stereotactically into the brain of immunodeficient mice (n = 20). Three months after tumor inoculation, magnetic resonance imaging and histology confirmed tumor engraftment in all 20 mice (100%) that obtained tissue transplants. The lesions invaded adjoining brain tissue with micro finger-shaped protrusions. Immunohistochemical comparison of the primary tumor and xenotransplants revealed a similar amount of proliferation (Mib-1) and cytokeratin expression pattern (KL-1). Whole tumor reconstruction using serial sections confirmed whirl-like cell clusters with nuclear β-catenin accumulations at the tumor brain border. These whirls were surrounded by a belt of Claudin-1 expressing cells, showed an activated epidermal growth factor receptor (EGFR) and distinct CD133 as well as p21(WAF1/Cip1) positivity, indicating a tumor stem cell phenotype. Consistent with our previous in vitro studies, intracranial xenotransplants of adaCP confirmed cells with nuclear β-catenin and activated EGFR being the driving force of tumor outgrowth. This model provides the possibility to study in vivo tumor cell migration and to test novel treatment regimens targeting this tumor stem cell niche.

Citing Articles

Correlations between the expression of molecules in the TGF-β signaling pathway and clinical factors in adamantinomatous craniopharyngiomas.

Jin L, Cai K, Wu W, Xiao Y, Qiao N, Liu F Front Endocrinol (Lausanne). 2023; 14:1167776.

PMID: 37854185 PMC: 10579895. DOI: 10.3389/fendo.2023.1167776.


Predictive Factors for Pediatric Craniopharyngioma Recurrence: An Extensive Narrative Review.

Serbis A, Tsinopoulou V, Papadopoulou A, Kolanis S, Sakellari E, Margaritis K Diagnostics (Basel). 2023; 13(9).

PMID: 37174978 PMC: 10177772. DOI: 10.3390/diagnostics13091588.


Single-cell RNA sequencing highlights intratumor heterogeneity and intercellular network featured in adamantinomatous craniopharyngioma.

Jiang Y, Yang J, Liang R, Zan X, Fan R, Shan B Sci Adv. 2023; 9(15):eadc8933.

PMID: 37043580 PMC: 10096597. DOI: 10.1126/sciadv.adc8933.


Integrative analyses identify HIF-1α as a potential protective role with immune cell infiltration in adamantinomatous craniopharyngioma.

Gao Q, Luo J, Pan J, Zhang L, Song D, Zhang M Front Immunol. 2022; 13:949509.

PMID: 36091021 PMC: 9450013. DOI: 10.3389/fimmu.2022.949509.


Rathke's cleft-like cysts arise from Isl1 deletion in murine pituitary progenitors.

Brinkmeier M, Bando H, Camarano A, Fujio S, Yoshimoto K, de Souza F J Clin Invest. 2020; 130(8):4501-4515.

PMID: 32453714 PMC: 7410063. DOI: 10.1172/JCI136745.


References
1.
Park J, Kim J, Park J, Huang S, Kwak S, Ryu K . Association of p21-activated kinase-1 activity with aggressive tumor behavior and poor prognosis of head and neck cancer. Head Neck. 2014; 37(7):953-63. DOI: 10.1002/hed.23695. View

2.
Hofmann B, Hollig A, Strauss C, Buslei R, Buchfelder M, Fahlbusch R . Results after treatment of craniopharyngiomas: further experiences with 73 patients since 1997. J Neurosurg. 2011; 116(2):373-84. DOI: 10.3171/2011.6.JNS081451. View

3.
Szeifert G, Sipos L, Horvath M, Sarker M, Major O, Salomvary B . Pathological characteristics of surgically removed craniopharyngiomas: analysis of 131 cases. Acta Neurochir (Wien). 1993; 124(2-4):139-43. DOI: 10.1007/BF01401137. View

4.
Yang J, Qu X, Russell P, Goldstein D . Interferon-alpha promotes the anti-proliferative effect of gefitinib (ZD 1839) on human colon cancer cell lines. Oncology. 2005; 69(3):224-38. DOI: 10.1159/000088070. View

5.
Whale A, Hashim F, Fram S, Jones G, Wells C . Signalling to cancer cell invasion through PAK family kinases. Front Biosci (Landmark Ed). 2011; 16(3):849-64. DOI: 10.2741/3724. View